Home/ Supplements/ Lysine/ L-Lysine Extra Strength 1000 mg

L-Lysine Extra Strength 1000 mg

product on market Tablet or Pill Bronson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine Extra Strength 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
100
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 500.0mg (159 products)

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Dicalcium Phosphate Magnesium Stearate Silicon Dioxide Hydroxypropyl Methylcellulose Polyethylene Glycol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take 1 tablet daily, preferably with a meal, or as directed by a healthcare professional.

Warnings & Precautions

Warning: If you are pregnant, nursing or taking any medications, consult your healthcare professional before use.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

L-Lysine Extra Strength High Potency 1000 mg per tablet

Healthy immune support Supports collagen synthesis

GMO-Free Gluten-Free Soy-Free

Lab Tested Made from High Quality Ingredients 100% Money Back 365 Day Guaranteed

Additional Information

Store at room temperature.

GMP Good Manufacturing Practice

Nutrition Questions or Comments? Call 1-800-235-3200 Mon.-Fri. 7 AM - 6PM MST Sat. 8 AM - 4:30 PM MST New

Metadata

Product Details

UPC / SKUX00398UBWX
DSLD Entry Date2024-08-22
Product TypeAmino acid/Protein
FormTablet or Pill
BrandBronson
DSLD ID317325
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.